Results for tag: "Lab Automation In Drug Discovery"

In the realm of pharmaceuticals, lab automation in drug discovery refers to the use of technology to conduct experiments without human intervention, thus streamlining the various stages of drug development. This process involves a range of automated systems, such as robotic instruments, software, and methodologies designed to manage and analyze large datasets, improve reproducibility, and reduce the likelihood of error. Lab automation is applied in numerous aspects of drug discovery, including high-throughput screening (HTS), genomics, proteomics, and compound handling and storage. The use of automation helps pharmaceutical companies expedite the drug discovery process, enhance the efficiency of research and development programs, and ultimately speed up the time it takes for new therapeutics to reach the market. Automation technology enables researchers to perform complex biochemical, genetic, or pharmacological tests rapidly and with precision, thus fostering the rapid identification of potential drug candidates. Several players dominate the lab automation in drug discovery market within the pharmaceutical industry. Prominent companies include Thermo Fisher Scientific Inc., Agilent Technologies, Beckman Coulter (part of Danaher Corporation), Hamilton Robotics, Tecan Group Ltd., PerkinElmer Inc., Qiagen, and Aurora Biomed. These firms offer a wide array of automated solutions tailored for the diverse needs of drug discovery applications, positioning themselves as integral partners to the pharmaceutical sector in its quest to innovate and improve human health. Show Less Read more